APA

Olmedo Martín R. V., Amo Trillo V., González Grande R. & Jiménez Pérez M. (20180618). Efficacy and safety of vedolizumab as a treatment option for moderate to severe refractory ulcerative colitis in two patients after liver transplant due to primary sclerosing cholangitis. : Revista espanola de enfermedades digestivas.

Chicago

Olmedo Martín Raúl Vicente, Amo Trillo Víctor, González Grande Rocío and Jiménez Pérez Miguel. 20180618. Efficacy and safety of vedolizumab as a treatment option for moderate to severe refractory ulcerative colitis in two patients after liver transplant due to primary sclerosing cholangitis. : Revista espanola de enfermedades digestivas.

Harvard

Olmedo Martín R. V., Amo Trillo V., González Grande R. and Jiménez Pérez M. (20180618). Efficacy and safety of vedolizumab as a treatment option for moderate to severe refractory ulcerative colitis in two patients after liver transplant due to primary sclerosing cholangitis. : Revista espanola de enfermedades digestivas.

MLA

Olmedo Martín Raúl Vicente, Amo Trillo Víctor, González Grande Rocío and Jiménez Pérez Miguel. Efficacy and safety of vedolizumab as a treatment option for moderate to severe refractory ulcerative colitis in two patients after liver transplant due to primary sclerosing cholangitis. : Revista espanola de enfermedades digestivas. 20180618.